JPH03172184A - Genome dna sequence - Google Patents

Genome dna sequence

Info

Publication number
JPH03172184A
JPH03172184A JP1309257A JP30925789A JPH03172184A JP H03172184 A JPH03172184 A JP H03172184A JP 1309257 A JP1309257 A JP 1309257A JP 30925789 A JP30925789 A JP 30925789A JP H03172184 A JPH03172184 A JP H03172184A
Authority
JP
Japan
Prior art keywords
sequence
dna sequence
genome
genome dna
transcription
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1309257A
Other languages
Japanese (ja)
Inventor
Akira Murasugi
村杉 章
Naoki Komiyama
小宮山 直樹
Sadatoshi Sakuma
貞俊 佐久間
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Milk Products Co Ltd filed Critical Meiji Milk Products Co Ltd
Priority to JP1309257A priority Critical patent/JPH03172184A/en
Publication of JPH03172184A publication Critical patent/JPH03172184A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

NEW MATERIAL:Genome DNA sequence shown by the formula substantially containing a range controlling transfer and termination of LZ-8 structural gene. USE:Efficiently producing LZ-8. PREPARATION:The title sequence is extracted and purified from Ganoderma lucidum as a raw material by conventional procedures.

Description

【発明の詳細な説明】 (産業上の利用分野) 本究明は、マンネンタケl CG*nodtrm*)菌
糸体由来の免疫抑制能を有する新規な蛋白質の構造遺伝
子を含んでいるマンネンタケのゲノムDNAに関するも
のである。
[Detailed Description of the Invention] (Industrial Application Field) The present study relates to the genomic DNA of C. chinensis, which contains the structural gene of a novel protein with immunosuppressive ability derived from the mycelia of C. chinensis (CG*nodtrm*). It is.

(従来の技術及び本発明が解決しようとする課題)マン
ネンタケ(1;xnoder*a lucidius)
は箋 ヒダナシタケ目サノレノコシカケ+4 (Pol
yporx+es)に属する担子菌で、霊芝とも呼ばれ
、古くから生薬として珍重されており、現在でも漢方薬
成分の一つとして、 またa!様食品として広く利用さ
れている。
(Prior Art and Problems to be Solved by the Present Invention) Cypress mushroom (1; xnoder*a lucidius)
Notebook Hidanashitake +4 (Pol
It is a basidiomycete that belongs to the genus yporx + es), and is also called reishi, and has been prized as a herbal medicine since ancient times, and is still used as an ingredient in Chinese herbal medicine. It is widely used as a food.

本発明省らは、先にマンネンタケの閑糸体内から免疫抑
制能を有する新規な蛋白質(以下LZ−8という)を抽
出MI1し、そのアミノ酸配列を特定し、また該アミノ
酸配列をコードするcDN^をクローニングした(特開
平1−2749医特願昭83−274552、The 
Journal of Blologlcal Che
*Istry 264. 472−478 (1989
)及びThe Journal of Biologi
cal Chesstry  2B4.  16372
−16377  (1989))。 LZ−8は、 N
宋端のアミノ酸がアセチル化されている110個のアミ
ノ鹸からなり、分子量はN末端のアセチル基を含めて1
2,420であり、lnvlvoの生理活性として、ア
レルギータイプI!f!(アナフィラキシー)、同■型
(インシュリン依存性糖尿病)、同■型(アルサス反応
)及び同■型(混合リンパ球反応)を抑制する作用をf
丁する。このことから、LZ−8は、アレルギー治療に
f『効であることが考えられる。
The Ministry of the Invention and others previously extracted a novel protein with immunosuppressive ability (hereinafter referred to as LZ-8) from the cephalothelium of C. chinensis, identified its amino acid sequence, and identified the cDN^ encoding the amino acid sequence. was cloned (Japanese Unexamined Patent Publication No. 1-2749, Medical Patent Application No. 83-274552, The
Journal of Bloglcal Che
*Istry 264. 472-478 (1989
) and The Journal of Biology
cal Chesstry 2B4. 16372
-16377 (1989)). LZ-8 is N
It consists of 110 amino acids in which Song Dynasty amino acids are acetylated, and the molecular weight is 1 including the N-terminal acetyl group.
2,420, and the physiological activity of lnvlvo is allergic type I! f! (anaphylaxis), isotype (insulin-dependent diabetes), isotype (Arthus reaction), and isotype (mixed lymphocyte reaction).
Ding. From this, it is considered that LZ-8 is effective in treating allergies.

本発Ill者らは更に、LZ−8を遺伝子工学的に効率
よ<製逍するために、LZ−8コーディング領坂 実質
的む5゜転写制t8領域を及び3′側の転写終結領域を
含むLZ−8ゲノムON^をクロー二冫グし、転写制御
に関与する構造を解明することにした (課題を解決するための手段) 本発明のゲノムロNAは、特聞平1−27490、或い
は特願IV1 83−274552に記載のマンネンタ
ケを原料として常法により抽出●桔製される。
In order to efficiently produce LZ-8 by genetic engineering, the present inventors further modified the LZ-8 coding region, including the 5° transcription-regulating t8 region and the 3' transcription termination region. We decided to clone the LZ-8 genome ON^ containing the LZ-8 genome and elucidate the structure involved in transcriptional control (means for solving the problem). It is extracted and produced by a conventional method using the stone mushroom described in Japanese Patent Application IV1 83-274552 as a raw material.

即ち、本発明に使用されるマンネンタケは、原色日本菌
頒図鑑(保育社版)、並びに伊藤誠也著日本菌類誌(I
賢堂版)に準じ同定された菌糸体であればいずれのもの
でもよい力q 菌株によって産生量にバラッ牛があった
り、或いは採取した菌株の地域差が存在する恐れがある
ため、本物質を効率的に得るには、微工研に寄託されて
いる微工研条寄m1826号(FERII IIP−1
828)を使用することが好ましい。
In other words, the mushrooms used in the present invention are published in the Illustrated Encyclopedia of Japanese Fungi (Yakushusha Edition) and the Journal of Japanese Mycology (I) written by Seiya Ito.
Any mycelium that has been identified according to the Kendo version) may be used.Since there may be variations in production depending on the strain, or there may be regional differences in the strains collected, this substance should not be used. In order to obtain it efficiently, the FERII IIP-1
828) is preferably used.

以下に本発明を実施例によって説明する.(実施例) 〈マンネンタケのゲノムON^の調製〉マンネンタケ菌
糸体(湿重量約20g)を、液体′g.素中で粉砕し、
10−の抽出用緩衝液(10d丁rls−MCI  p
H  7.5、  10  mlI  N@CI、 2
5  all  EDTA:  以下TEII街液とい
う)にV濁し、更に最終濃度が1%になるようにSOS
を加え九 次にこの懸濁液にIf myのプロテアーゼ
Kを加え、37℃で2時間処理しヘ この懸濁液に5 
H NaCIをl一加えてから、フェノール処理を5回
繰り返した 水層をクロロフォルム/イソアミルアルコ
ール(24 : I)で2回抽出後、2.5倍量のエタ
ノールを加えてゲノムON^を沈澱させた この沈澱を
80%エタノールで洗った後、10−のTEllIi液
に溶解させた この試料には多量のRN^が含まれてい
るので、これを除くために200μgのりボヌクレアー
ゼAを加えて37℃で30分間保温してRNAを分解し
、河びフェノール処理とエタノール沈澱を繰り返し、最
終的に約200μgのゲノムDNAを得九< LZ−8
ゲノムロNA (1!8) ノクO−二7グ〉前記で得
た12μgのゲノムON^を制限醇素EcoR I及び
Sex Iで完全消化し、0.8%アガロースゲル電気
泳動でDNA断片を分画し九 このときLZ−8ゲノム
DN^は約5 kbの断片に含まれていることが判って
いたので、 4〜5kbの両分のDNA断片をこのゲル
から抽出した1】。Scx Iによる切断では平滑末端
を生じるので、直接この断片にEcoR Iリンヵー(
pCCGAATTCGG; TAKAI^社I!)を連
結させ九 次いでリンカーをEcoR Iで泊化後、ア
ガロースゲル電気泳動して目的とするDNA断片を分離
した 回収されたDNAの約1/3filを rugの
λgtl07−ム(Staratagene社製)に連
結させ、Gigapack Golds  (Stra
tagene社製のバッケージング●キット)を使い、
添付されているプロトコールに記載された方法に従って
λフT−ジにパッケージングし九 このライブラリーは
約25万クローンを含んでい九約25,000のプラー
クを5枚のプレート(直径90 am)にまき、ニトロ
セルロースフィルターにリフトした。陽性クローンのス
クリーニングのためのプロープとしては既に取得したL
Z−8のクローン化cDN^(特願昭63−27455
2を参照)を川いた このcDNA (520 bp)
はpUcI9のEcoR I部位に組み込まれていたの
で、まずEeoR Iで消化し、アガロースゲル電気泳
動により分画してcDN^をゲルから抽出し九 このc
DN^約50 ngをAmersham社のMultl
prlme DNA Labelllng Syste
msにより、”P−dCTP (3,000 CI/g
aol)で標識し九 次いでファージON^を固定化し
た前述のニトロセルロールフィルターを、4 X  S
SC (l X  SSCは0.15 M NaCIと
 0.015 11クエン酸を含むL  10 X F
BP(l X FOPは0.02%フイコール、0.0
2%BS^、0.02%ポリビニルビロリドン及び0.
1%SOSを含む)を含む溶液で、65℃、1時間以上
処理してプレハイプリダイズし、4 X SSCS5 
X FOP. 0.1 at/−サケ稍子ON^及び2
.8 X 10’ cps/d  ”P−cDN^を含
む溶液で、65℃で一晩ハイプリダイゼーシーンを行う
九 八イブリダイゼーシーン終了後、フィルターは0.
05 X SSllA0.1%SOSの溶液を使い、室
温で20分間2回、そして65℃で30分間洗浄した後
、オートラジオグラムにかけたところ、3個の強いシグ
ナルが見い出され九 そこでそれぞれのシグナルに対応
するファージを請製し九 最終的には1個のクローンが
その塩基配列の分析からLZ−8ゲノムON^を含んで
いることが確認されら < LZ−8ゲ/ ムDNA ( +te)の構造〉上
述の方法に′より取得したLZ−8遺伝子を含むマンネ
ンタケのゲノムON^断片の制限醇素地図を第l図に示
した この図中、園で表される領域は、後述する第2図
に記載の塩基配列の領域を示す。
The present invention will be explained below using examples. (Example) <Preparation of the genome ON^ of Cinnamon lucidum> The Cinnamon mycelium (wet weight about 20 g) was mixed with a liquid 'g. Grind in the air,
10-ml extraction buffer (10mls-MCI p
H 7.5, 10 ml I N@CI, 2
5 All EDTA (hereinafter referred to as TEII street solution) is mixed with V, and then SOS is added so that the final concentration is 1%.
Next, if my protease K was added to this suspension and treated at 37°C for 2 hours.
After adding one liter of H NaCI, the phenol treatment was repeated five times.The aqueous layer was extracted twice with chloroform/isoamyl alcohol (24:I), and 2.5 times the amount of ethanol was added to precipitate the genome ON^. After washing this precipitate with 80% ethanol, it was dissolved in 10% TELLIi solution. This sample contains a large amount of RN^, so in order to remove it, 200 μg of bonuclease A was added to the solution. The RNA was degraded by incubation at ℃ for 30 minutes, followed by repeated phenol treatment and ethanol precipitation, and finally approximately 200 μg of genomic DNA was obtained.
Genome LoNA (1!8) Noku O-27g> 12 μg of the genome ON^ obtained above was completely digested with restriction dyes EcoR I and Sex I, and the DNA fragments were separated by 0.8% agarose gel electrophoresis. At this time, it was known that the LZ-8 genome DN^ was contained in a fragment of approximately 5 kb, so both DNA fragments of 4 to 5 kb were extracted from this gel 1]. Since Scx I cleavage produces blunt ends, EcoR I linkers (
pCCGAATTCGG; TAKAI^ Company I! ) and then ligated the linker with EcoR I and separated the desired DNA fragment by agarose gel electrophoresis. Approximately 1/3 fil of the recovered DNA was transferred to RUG's λgtl07-me (manufactured by Stratagene). Gigapack Golds (Stra
Using Tagene's packaging ● kit),
This library contains approximately 250,000 clones. Approximately 25,000 plaques were packaged on 5 plates (90 am diameter) according to the method described in the attached protocol. and lifted onto a nitrocellulose filter. The previously obtained L was used as a probe for screening positive clones.
Cloned cDN of Z-8 (patent application 1986-27455)
This cDNA (520 bp)
was integrated into the EcoR I site of pUcI9, so we first digested it with EeoR I, fractionated it by agarose gel electrophoresis, and extracted the cDN^ from the gel.
Approximately 50 ng of DN^ was added to Amersham's Multl.
prlme DNA Labeling System
ms, “P-dCTP (3,000 CI/g
The aforementioned nitrocellulose filter labeled with aol) and immobilized with phage ON^ was then filtered with 4×S
SC (l x SSC is L 10 x F containing 0.15 M NaCI and 0.015 11 citric acid)
BP(l x FOP is 0.02% Ficoll, 0.0
2% BS^, 0.02% polyvinylpyrrolidone and 0.02% polyvinylpyrrolidone.
Prehybridize by treating with a solution containing 1% SOS at 65°C for over 1 hour, and then
X FOP. 0.1 at/-Sake Kenko ON^ and 2
.. Perform a hybridization scene overnight at 65°C with a solution containing 8 x 10'cps/d''P-cDN^.After the hybridization scene is completed, the filter is heated to 0.
After washing twice for 20 minutes at room temperature and 30 minutes at 65°C using a solution of 0.1% SOS, three strong signals were found on the autoradiogram. Finally, one clone was confirmed to contain the LZ-8 genome ON^ from analysis of its nucleotide sequence. Structure〉The restriction map of the ON^ fragment of the LZ-8 gene containing the LZ-8 gene obtained by the method described above is shown in Figure 1. The region of the base sequence shown in the figure is shown.

更に118を含むロN^の0.5 〜I kb断片をp
Ucl9にサブクローンし、必要に応じてプライマーを
作成しながらSanger法2》により塩基配列を決定
し九この結果は第2図に示した この図中、・・は回転
対称を示す塩基配外    はCCAAT類似配列を含
む構造、    はT^丁^ボックス、    は点、
    はスプライスに関係すると思われる塩基配夕1
1,  ↓はボリA付加部位をそれぞれ示す。
Furthermore, p
The nucleotide sequence was determined by subcloning into Ucl9 and using the Sanger method (2) while creating primers as necessary.The results are shown in Figure 2.In this figure, ... indicates rotational symmetry. Structures containing CCAAT-like sequences, are T^Ding^ boxes, are dots,
is the base sequence 1 that is thought to be related to splicing.
1 and ↓ indicate the BoliA addition sites, respectively.

LZ−8Ffi白質が翻訳される領域と3゜側の非翻訳
領域の塩基配列は、poly(^)を除いて、先に出願
した特廊昭63−274552に記載のcDNAの塩基
配列と全く同じである。5I側の非翻訳領域ではcDN
Aでは欠けている配列が存在する(第2図の塩基番号で
54〜114;以下塩基番号は全て第2図のものである
).この部分はイントロンであり、LZ−8遺伝子が転
写されて成熟■RN^に?jる前にスプライスさ%  
cDNAでは消失したものと思われる。スプライス部分
の5゜側のGT及び3゛側の^Gという配列はよく保存
されており1 植物や脊椎動物のconser+sus
 sequenceと矛盾せず、また脊椎動物や,ウィ
ルスに共通の枝分かれ部位の配列も存在する(塩基番号
97〜I01)。
The nucleotide sequence of the translated region of LZ-8Ffi white matter and the untranslated region on the 3° side is exactly the same as the cDNA nucleotide sequence described in the previously filed Tokuro Sho 63-274552, except for poly(^). It is. cDNA in the untranslated region on the 5I side
There is a missing sequence in A (base numbers 54 to 114 in Figure 2; all base numbers below are from Figure 2). This part is an intron, and the LZ-8 gene is transcribed into the mature ■RN^? spliced before cutting
It seems that it has disappeared from cDNA. The sequences GT on the 5° side and ^G on the 3° side of the splice are well conserved1.conser+sus in plants and vertebrates
There is also a branching site sequence that is consistent with the sequence and is common to vertebrates and viruses (base numbers 97 to 101).

しかし、酵母の枝分かれ部位の塩基配列と同じ配列1》
は存在しない. 二種類のオリゴヌクレオチドを用いたプライマー伸長法
噌》により、転写開始点は塩基番号!のヌクレオチドで
あることが判明した この塩基の両側には(;ACAC
という配列があり、その外側にビリミジンのクラスター
が存在するという非常に特徴的な慴逍が見られら これ
はまた、酵母の転写開始点の一つであるRRYRRII
 (Rはプリン塩&Yはビリミジン塩基を示す)にも合
致している。
However, the sequence 1 is the same as the base sequence of the branching site in yeast.
does not exist. Using the primer extension method using two types of oligonucleotides, the transcription start point is the base number! The nucleotides on both sides of this base were found to be (;ACAC
This sequence has a very characteristic feature of having a cluster of virimidine on the outside.
(R represents purine salt & Y represents pyrimidine base).

この転写開始点から約80塩基上流にはTAT^ボック
スを含む配列、ccgtataaaaggがあり、これ
はLZ−8 mRNAの転写にffl栗な役割をはたし
ているものと思われる。
Approximately 80 bases upstream from this transcription start point is a sequence containing a TAT^ box, ccgtataaaagg, which seems to play an important role in the transcription of LZ-8 mRNA.

塩基配列−259及び−174から龜 CCAATボッ
クスに類似した配列を含むgcaattcが始まってい
る.また、塩証番号−406及び−168からは、酵母
GAL遺伝子群のUAS (上流の転写促進領域)にあ
るような回転対魚性を示す塩基配列が始まっている(第
2図中で・・で示しな)●〉。これらの塩基配列もLZ
−8 mRNAの転写を強める働きを有している可能性
がある。
gcaattc, which contains a sequence similar to the CCAAT box, begins from base sequences -259 and -174. Furthermore, base sequences exhibiting rotational anti-fish characteristics, such as those found in the UAS (upstream transcriptional promotion region) of the yeast GAL gene group, start from salt identification numbers -406 and -168 (in Figure 2... Please indicate)●〉. These base sequences are also LZ
-8 It may have the effect of enhancing transcription of mRNA.

動物細胞においては■RN^の転写がpoly(A)付
加部位よりも遥か下流まで行われることが知られている
1+, マンネンタケにおいても動物細胞のように■I
IN^の転写がpoly(A)付加部位よりも逼か下流
まで行われているならば、LZ−a mRNAは第3図
に示す二次構造を形成することが考えられる。このよう
な構造をとるとすれば、poly(A)の付加部位はル
ープ部分に存在し、動物細胞のpoly(A)シグナル
といわれるAAUAA^●}と類似していて、しかも酵
母の■IIN^の3′末端付近によく見られるUAAt
lもまたループ部分に位置することになる。鵬RNAが
このような二次II造をとることによって、正確な位置
にpoly(A)が付加されることが考えられII、ま
た分解酵素の働きを多少μりとも受けにくくなり、■R
NAの安定性や寿命に関係する可能性がある。
In animal cells, transcription of ■RN^ is known to occur far downstream from the poly(A) addition site1+, and in C. chinensis, the transcription of ■I
If transcription of IN^ is performed up to a point downstream of the poly(A) addition site, LZ-a mRNA is likely to form the secondary structure shown in FIG. 3. If such a structure is adopted, the addition site of poly(A) exists in the loop part, and is similar to AAUAA^●, which is said to be the poly(A) signal in animal cells, and is similar to ■IIN^ in yeast. UAAt often found near the 3′ end of
l will also be located in the loop portion. It is thought that by adopting such a secondary structure of Peng RNA, poly(A) is added at a precise position, and it becomes less susceptible to the action of degrading enzymes, and ■R
This may be related to NA stability and lifespan.

LZ−8af白質はマンネンタケ閑糸体の中で多量に作
られており、従ってLZ−4ffi白質に対応する一I
N^の量も多い.その理由として、上述のLZ−8の構
造遺伝子の5゜側の特徴ある塩基配列力へ プロモータ
ーやエンハンサー或いは効率のよい転写開始点などとし
て働いている可能性がある.また、3゜側のpo1yO
)付加部位より下流の塩基配列は,  mRNAの前駆
体に転写されたときに、I)OIF(A)の付加部位を
ループ部分に持ち、かつ分解酵素に対して安定な二次構
造をとる可能性が考えられる。更に、イントロンの?l
在自体や翻訳開始メチオニンコドンの直前の塩基配列も
また最終産物LZ−8蛋白質の生合成の効車を上げる作
用のあることも考えられる。
LZ-8af white matter is produced in large amounts in the medulla, and therefore, the LZ-8af white matter corresponds to the LZ-4ffi white matter.
The amount of N^ is also large. The reason for this may be that the characteristic nucleotide sequence on the 5° side of the LZ-8 structural gene mentioned above functions as a promoter, enhancer, or efficient transcription initiation site. Also, po1yO on the 3° side
) The base sequence downstream of the addition site is such that when it is transcribed into the mRNA precursor, it has the possibility of forming a secondary structure that has the OIF (A) addition site in the loop and is stable against degrading enzymes. Possible gender. Furthermore, what about introns? l
It is also thought that the nucleotide sequence immediately before the methionine codon that initiates translation has the effect of increasing the efficiency of the biosynthesis of the final product LZ-8 protein.

引用文献 1.   Recovery  of  DNA  f
rom  Low  leltlng  Tem−pe
rature Agarose. p.I70 In″
Ilolecular Clon−ngt^ Iabo
ratory Mannual″(ads. llan
latlg,T., Frltsch, E.F., 
l Sambrook, J.) ColdSprin
g Harbor Laboratory (1982
)2、Sanger, F., Mlcklen, S
. & Coulson, A.Il.(+977) 
Proe. Natl.^cad. Scl. USA
 74. 5483−3.  RNA sp目clng
, pp.+31−206 In ”Transcrl
p−tlonand Spllclng’ (eds.
 HaI+es, B.D. I Glover,D.
M.)IRL Press (+988)4.517ッ
ピングとプライマー伸長法、PP241−25Fhr続
生化学実験講座l(日本生化学会IEI)道伝子研究法
■、組換えDNA技術」 (東京化学同人)  (19
88年) 5.  Hahn. S.. }four, E.T.
 & Guarenta, L.(+985) Pro
c. Natl. Acad. Scl. LIS^8
2, 8582−6. 深沢ら、(+985) af白
質核酸酵t.  30,  1491−?.  Ter
mlnatlon and 3’ Procassln
g of Euka−ryotlc  l)IA  p
p.97−129  1n  ″丁ranscrlpt
lon  andSplicing” (ads. N
ames, B.D. l Glover, 0.11
.)IRL Press (1988) 8、foychlk. R.P., Lyons, R
.H., Post, L. IRottman, F
.lI. (+984) Proc. Natl. A
cad. Scl.IJSA,  81.  3944
−39489. 8rake, A.J., Jull
us, D.J. i Thorner, J.(+9
83) Ilol. Cell. Bllol. 3.
 1440−1450図面の簡単な説明 第1図はLZ−8道伝子を含むマンネンタヶゲノムON
^のEcoR I及びSea I切断断片の制限酵素地
図を示す。第2図はLZ−8の構造遺伝子を含むゲノム
ONAの塩基配列を示す。m3図はLZ−8遺伝子から
転写された■RNAの推定二次構造を示す。
References 1. Recovery of DNA f
rom Low letlng Tem-pe
rate Agarose. p. I70 In''
Ilolecular Clone-ngt^ Iabo
ratory Manual” (ads. llan
latlg, T. , Frltsch, E. F. ,
l Sambrook, J. ) Cold Sprin
g Harbor Laboratory (1982
)2, Sanger, F. , Mlklen, S.
.. & Coulson, A. Il. (+977)
Proe. Natl. ^cad. Scl. USA
74. 5483-3. RNA sp.clng
, pp. +31-206 In "Transcrl"
p-tronand Spllclng' (eds.
HaI+es, B. D. I Glover, D.
M. ) IRL Press (+988) 4.517 Ping and Primer Extension Method, PP241-25Fhr Follow-up Biochemistry Experiment Course I (Japan Biochemical Society IEI) Michiden Research Method ■, Recombinant DNA Technology” (Tokyo Kagaku Doujin) (19
1988) 5. Hahn. S. .. }four, E. T.
& Guarenta, L. (+985) Pro
c. Natl. Acad. Scl. LIS^8
2, 8582-6. Fukazawa et al. (+985) af white matter nucleic acid enzyme t. 30, 1491-? .. Ter
mlnatlon and 3' Procassln
g of Euka-ryotlc l)IA p
p. 97-129 1n ″Dranscrlpt
lon and Splicing” (ads.N
ames, B. D. l Glover, 0.11
.. ) IRL Press (1988) 8, foychlk. R. P. , Lyons, R.
.. H. , Post, L. I.Rottman, F.
.. lI. (+984) Proc. Natl. A
cad. Scl. IJSA, 81. 3944
-39489. 8rake, A. J. , Jull
us, D. J. i Thorner, J. (+9
83) Ilol. Cell. Blol. 3.
Brief explanation of the 1440-1450 drawings Figure 1 shows the LZ-8 genome containing the LZ-8 gene.
A restriction enzyme map of the EcoR I and Sea I cleavage fragment of ^ is shown. FIG. 2 shows the base sequence of the genome ONA containing the structural gene of LZ-8. Figure m3 shows the estimated secondary structure of RNA transcribed from the LZ-8 gene.

以上 出 願 人 明 治 乳 業 株 式 会 社 第1図 LZ−8遺伝子CIz8))を含むマンネンタ
ケ・ゲノムDNAのEcoR I /Sea I断片の
制限酵素地図g g uuucgac LZ8 mRNA  3 ’ 末端の推定二次構造 第2図 Ltca ttcLggagggaact tgaa 
Lgtcctscggca taccaagtggca
 tit H tcagcagggg t tgca 
tccagg Lccacctgcggtgcas t
 tcggttccatgtacttgcagggcc
tcgcacgtctt*tgcaccctggttt
aam tea tcz ttaaaCggcgctc
cgg t tgccg t etas a agga
cggcaaagLgagccetcccccttea
mtaacccceLamCttctgccccgca
gc^丁CI+8^TG TCC GAC ACT G
CC TTG ATC TTC AGG CTC GC
C TGG  164IktSerAspThrAle
LeuIIsPheArgLau▲laTrp+2GA
C GTG AAG AAG CTC TCG TTC
 l;AC TAC ACC CCG AAC  19
0Asp N’al Lys Lys Leu Ser
 Pha Asp Tyr Thr Pro Asn 
  24TGG Ili[;C CGC GGC AA
C CCC AAC^^C TTC ATC GAC 
ACT  226Trp Gly Arg Gly A
sn Pro Asn Asr+ Phe Ile A
sp Thr  3BGTC  ACC  TTC  
CCG  ^^A  GTC  TTG  ACC  
GAC  AAG  GC(i  丁^C  262V
al  丁hr  Phe  Pro  LyII V
al  Leu  Thr  ^sp  Lym Al
a  Tyr    48ACG TAC CGC G
TC GCC (;TC TCC GGA CGG A
AC CTC GGC  298Thr Tyr^rg
 V@l^lm Vil 5er Gly^rt As
nLeu Gly  60[;TGAAACCCTCG
丁ACGCGGTCGAGAGC(;ACGGCTCG
334▼ml Lys Pro Ser Tyr Al
aYal Glu Ser Asp Gly Ser 
 72Xho目 CAG^^G GTC AAC TTC CTC GA
G TAC AAC TCC GGG TAT  37
GGln LyIIVml Asn Ph1Leu G
lu Tyr Asn Sar Gly Tyr  8
4GGC ATA GCG GAC ACG^^C A
CG ATC CAG GT(; TTC GTT  
408(ily II@AI−▲in Thr Lan
 Thr Ila Gln Val Phe V@1 
  98▼a1 ^mp  Pro  Asp Thr
  ▲sn Asn  Asp  Pha  IIs 
 IIs  AleCAG TGG^^C TAG  
                  ^Gln Tr
p Asn End
Applicant Meiji Dairies Co., Ltd. Figure 1 Restriction enzyme map of the EcoRI/Sea I fragment of C. chinensis genome DNA containing the LZ-8 gene CIz8)) Figure 2 Estimated secondary structure of LZ8 mRNA 3' end Ltca ttcLggaggaact tgaa
Lgtcctscggca taccaagtggca
tit H tcagcagggg t tgca
tccag Lccacctgcggtgcas t
tcggttccatgtacttgcagggcc
tcgcacgtctt*tgcacctggttt
aam tea tcz ttaaaCggcgctc
cgg t tgccg t etas a agga
cggcaaagLgagccetcccccttea
mtaacccceLamCttctgccccgca
gc^Ding CI+8^TG TCC GAC ACT G
CC TTG ATC TTC AGG CTC GC
C TGG 164IktSerAspThrAle
LeuIIsPheArgLau▲laTrp+2GA
C GTG AAG AAG CTC TCG TTC
l;AC TAC ACC CCG AAC 19
0Asp N'al Lys Lys Leu Ser
Pha Asp Tyr Thr Pro Asn
24TGG Ili[;C CGC GGC AA
C CCC AAC^^C TTC ATC GAC
ACT 226Trp Gly Arg Gly A
sn Pro Asn Asr+ Phe Ile A
sp Thr 3BGTC ACC TTC
CCG ^^A GTC TTG ACC
GAC AAG GC (i ding^C 262V
al dinghr Phe Pro LyII V
al Leu Thr ^sp Lym Al
a Tyr 48ACG TAC CGC G
TC GCC (;TC TCC GGA CGG A
AC CTC GGC 298Thr Tyr^rg
V@l^lm Vil 5er Gly^rt As
nLeu Gly 60[;TGAAACCCTCG
dingACGCGGTCGAGAGC(;ACGGCTCG
334▼ml Lys Pro Ser Tyr Al
aYal Glu Ser Asp Gly Ser
72Xho CAG^^G GTC AAC TTC CTC GA
G TAC AAC TCC GGG TAT 37
GGln LyIIIVml Asn Ph1Leu G
lu Tyr Asn Sar Gly Tyr 8
4GGC ATA GCG GAC ACG^^C A
CG ATC CAG GT (; TTC GTT
408(ily II@AI-▲in Thr Lan
Thr Ila Gln Val Phe V@1
98▼a1 ^mp Pro Asp Thr
▲sn Asn Asp Pha IIs
IIs AleCAG TGG^^C TAG
^Gln Tr
p Asn End

Claims (1)

【特許請求の範囲】 1、LZ−8構造遺伝子の転写及び終結を制御する領域
を実質的に含有する下記ゲノムDNA配列。 −446 ttcattctggagggaacttgaatgt
cctacggcataccaagtggcat−33
9 tatatcaccttcggatatcgccatc
cataaccaacgtctcaaccccg−35
2 agatggacgtcatctggaggtaacg
accaaggcggtcttccggcaac−30
5 tgtggtctcgaagacgtgaggcgtt
tacaaggttggacatctcgggg−25
8 caattctgccaaactcgcaaggaga
atgtaccgtcctatcacctgca−21
1 gtggtcagcaggggttgcatccagg
tccacctgcggtgcaattcggt−16
4 tccctgtggcttgcagggcctcgca
cgtcgtatgcaccctggtttac−11
7 atcatcgtgaaacggcgctccggtt
gccgtataaaaggacggcaaag−70 gcggccagtggacttcagcacctgc
tcttgtacccacttctagtaag−23
+124 tcgcataccacctctcctgacagCG
ACAGGTTCACTGACTAGTTCAT71 AGTCCACAGCTCTTTGCCTTACAAT
CAAGgtttgccgacaccctctt118 tgagccctcccccttcaataacccc
ctaacttctgccccgcagCATC154 ATGTCCGACACTGCCTTGATCTTCA
GGCTCGCCTGGMetSerAspThrAl
aLeuIlePheArgLeuAlaTrp190 GACCTGAAGAAGCTCTCGTTCGACT
ACACCCCGAACAspValLysLysLe
uSerPheAspTyrThrProAsn228 TGGGGCCGCGGCAACCCCAACAACT
TCATCGACACTTrpGlyArgGiyAs
nProAsnAsnPheIleAspThr282 GTCACCTTCCCGAAAGTCTTGACCG
ACAAGGCGTACValThrPheProLy
sValLeuThrAspLysAlaTyr298 ACGTACCGCGTCGCCGTCTCCGGAC
GGAACCTCGGCThrTyrArgValAl
aValSerGlyArgAsnLeuGly334 GTGAAACCCTCGTACGCGGTCGAGA
GCGACGGCTCGValLysProSerTy
rAlaValGluSerAspGlySer370 CAGAAGGTCAACTTCCTCGAGTACA
ACTCCGGGTATGlnLysValAsnPh
eLeuGluTyrAsnSerClyTyr408 GGCATAGCGGACACGAACACGATCC
AGGTGTTCGTTGlyIleAlaAsnTh
rAsnThrIleGlnValPheVal442 GTCGACCCCGACACCAACAACGACT
TCATCATCGCCValAspProAspTh
rAsnAsnAspPheIleIleAla485 CAGTGGAACTAGGAGGAGGCAGTGA
CTGACCCCTGGCGGTCTAGlnTrpA
snEnd 532 ATCTGCGGGCCACTGTGGGGGAGGG
GCATCGCCCATCAGCTTCCTTG579 TCTCATAATCATGCCCGTGTAACAA
TTGTAAATCGACCTTGTTGTAC626 CATGCAtccagcttttgtggtgtgc
cgtcttatgtttggttgaatgc
[Scope of Claims] 1. The following genomic DNA sequence substantially containing a region controlling transcription and termination of the LZ-8 structural gene. -446 ttcattctggagggaacttgaatgt
cctacggcataccaagtggcat-33
9 tatatcaccttcggatatcgccatc
cataaccaacgtctcaacccccg-35
2 agatggacgtcatctggaggtaacg
accaaggcggtcttccggcaac-30
5 tgtggtctcgaagacgtgaggcgtt
tacaaggttggacatctcgggg-25
8 caattctgccaaactcgcaaggaga
atgtaccgtcctatcacctgca-21
1 gtggtcagcaggggttgcatccagg
tccacctgcggtgcaattcggt-16
4 tccctgtggcttgcagggcctcgca
cgtcgtatgcaccctggtttac-11
7 atcatcgtgaaacggcgctccggtt
gccgtataaaaggacggcaaag-70 gcggccagtggacttcagcacctgc
tcttgtacccacttctagtaag-23
+124 tcgcataccacctctcctgacagCG
ACAGGTTCACTGACTAGTTCAT71 AGTCCACAGCTCTTTGCCTTACAAT
CAAGgtttgccgacaccctctt118 tgagccctcccccttcaataaccccc
ctaacttctgccccgcagCATC154 ATGTCCGACACTGCCTTGATCTTCA
GGCTCGCCTGGMetSerAspThrAl
aLeuIlePheArgLeuAlaTrp190 GACCTGAAGAAGCTCTCGTTCGACT
ACACCCCGAACAspValLysLysLe
uSerPheAspTyrThrProAsn228 TGGGGCCGCGGCAACCCCCAAACAACT
TCATCGACACTTrpGlyArgGiyAs
nProAsnAsnPheIleAspThr282 GTCACCTTCCCGAAAGTCTTGACCG
ACAAGGCGTACValThrPheProLy
sValLeuThrAspLysAlaTyr298 ACGTACCGCGTCGCCGTCTCCGGAC
GGAACCTCGGCThrTyrArgValAl
aValSerGlyArgAsnLeuGly334 GTGAAAACCCTCGTACGCGGTCGAGA
GCGACGGCTCGValLysProSerTy
rAlaValGluSerAspGlySer370 CAGAAGGTCAACTTCCTCGAGTACA
ACTCCGGGTATGlnLysValAsnPh
eLeuGluTyrAsnSerClyTyr408 GGCATAGCGGACACGAACACGATCC
AGGTGTTCGTTGlyIleAlaAsnTh
rAsnThrIleGlnValPheVal442 GTCGACCCCGACACCAACAACGACT
TCATCATCGCCValAspProAspTh
rAsnAsnAspPheIleIleAla485 CAGTGGAACTAGGAGGAGGCAGTGA
CTGACCCCTGGCGGTCTAGlnTrpA
snEnd 532 ATCTGCGGGCACTGTGGGGGAGG
GCATCGCCCATCAGCTTCCTTG579 TCTCATAATCATGCCCGTGTAACAA
TTGTAAATCGACCTTGTTGTAC626 CATGCAtccagcttttgtggtgtgc
cgtcttatgtttggttgaatgc
JP1309257A 1989-11-30 1989-11-30 Genome dna sequence Pending JPH03172184A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1309257A JPH03172184A (en) 1989-11-30 1989-11-30 Genome dna sequence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1309257A JPH03172184A (en) 1989-11-30 1989-11-30 Genome dna sequence

Publications (1)

Publication Number Publication Date
JPH03172184A true JPH03172184A (en) 1991-07-25

Family

ID=17990822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1309257A Pending JPH03172184A (en) 1989-11-30 1989-11-30 Genome dna sequence

Country Status (1)

Country Link
JP (1) JPH03172184A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007535299A (en) * 2003-09-17 2007-12-06 益生生抜▲開▼▲発▼股▲フン▼有限公司 Fungal immunoregulatory protein (FIP) purified from microorganisms and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007535299A (en) * 2003-09-17 2007-12-06 益生生抜▲開▼▲発▼股▲フン▼有限公司 Fungal immunoregulatory protein (FIP) purified from microorganisms and uses thereof

Similar Documents

Publication Publication Date Title
CA2074943C (en) Process for the enzymatic cleavage of recombinant proteins using iga proteases
CA1296273C (en) Recombinant methods for production of serine protease inhibitors and methods for isolation of same
US5262309A (en) Terminal modifications of tumor necrosis factor
JP6039710B2 (en) Method for producing L-amino acid
JPH025869A (en) Dna sequence, recombinant dna molecule and lipocortins iii, iv, v, vi
TW205070B (en)
JPH03172184A (en) Genome dna sequence
US4935351A (en) Process for preparing oligopeptide
JPS59135892A (en) Dna coding signal aminoacid sequence and dna containing the same
CA2372097A1 (en) Epoxide hydrolases of aspergillus origin
EP0092829B1 (en) Process for semi-synthesis of human insulin and alkaline protease for use therein
RU2337966C2 (en) Preparation of recombinant human serum albumin and method of its production
KR101806601B1 (en) Crystal structure of human Mus81-Eme1-DNA complex and preparing method thereof
JP3388264B2 (en) Aminopeptidase and method for producing the same
JP3737252B2 (en) Method for recovering and purifying protein having epidermal growth factor activity
CN112522246A (en) Method for artificially constructing chitin corpuscle multienzyme complex scaford-ChiC-ChiA-sg and application
An et al. cDNA cloning of a hnRNP A1 isoform and its regulation by retinol in monkey tracheobronchial epithelial cells
JP6088973B2 (en) New amidase
CN118216506A (en) Application of arbutin in resisting tomato yellow leaf curl virus
JPH0759574A (en) Novel dna
JP2672088B2 (en) DNA base sequence useful for the same purpose as gene recombination method for production of serine protease inhibitor
JPS6143988A (en) Novel cerulein plasmid
JP2003250559A (en) Gene encoding new enzyme catalyzing sugar-transferring reaction, and method for producing the enzyme
EP0706567B1 (en) Peptide family, designated as xenonins
WO2020000450A1 (en) Human cd272 gene-targeting novel rnai fragment, rnai carrier, preparation method for same, and applications thereof